Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C, López-Barcons L, Gonzáles-Garrigues M, Navarro P, Lozano E, Rodrigo I, Gamallo C, Cano A, Fabra A, Quintanilla M. Caulín C, et al. Among authors: lozano e. Mol Carcinog. 1996 Feb;15(2):104-14. doi: 10.1002/(SICI)1098-2744(199602)15:2<104::AID-MC3>3.0.CO;2-J. Mol Carcinog. 1996. PMID: 8599577
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
Martinez-Becerra P, Vaquero J, Romero MR, Lozano E, Anadon C, Macias RI, Serrano MA, Grañé-Boladeras N, Muñoz-Bellvis L, Alvarez L, Sangro B, Pastor-Anglada M, Marin JJ. Martinez-Becerra P, et al. Among authors: lozano e. Mol Pharm. 2012 Jun 4;9(6):1693-704. doi: 10.1021/mp300028a. Epub 2012 May 1. Mol Pharm. 2012. PMID: 22524153
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
Merino-Azpitarte M, Lozano E, Perugorria MJ, Esparza-Baquer A, Erice O, Santos-Laso Á, O'Rourke CJ, Andersen JB, Jiménez-Agüero R, Lacasta A, D'Amato M, Briz Ó, Jalan-Sakrikar N, Huebert RC, Thelen KM, Gradilone SA, Aransay AM, Lavín JL, Fernández-Barrena MG, Matheu A, Marzioni M, Gores GJ, Bujanda L, Marin JJG, Banales JM. Merino-Azpitarte M, et al. Among authors: lozano e. J Hepatol. 2017 Jul;67(1):72-83. doi: 10.1016/j.jhep.2017.02.017. Epub 2017 Feb 22. J Hepatol. 2017. PMID: 28237397 Free PMC article.
Molecular Bases of Chemoresistance in Cholangiocarcinoma.
Marin JJG, Lozano E, Briz O, Al-Abdulla R, Serrano MA, Macias RIR. Marin JJG, et al. Among authors: lozano e. Curr Drug Targets. 2017;18(8):889-900. doi: 10.2174/1389450116666150223121508. Curr Drug Targets. 2017. PMID: 25706108 Review.
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
Macias RIR, Banales JM, Sangro B, Muntané J, Avila MA, Lozano E, Perugorria MJ, Padillo FJ, Bujanda L, Marin JJG. Macias RIR, et al. Among authors: lozano e. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1468-1477. doi: 10.1016/j.bbadis.2017.08.002. Epub 2017 Aug 4. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28782657 Free article. Review.
253 results